Condition: Breast Cancer · Triple Negative Breast Cancer · HER2-positive Breast Cancer · Sponsor: European Institute of Oncology
This single arm study aims to evaluate the efficacy and safety of a non-surgical approach, consisting of radiotherapy (RT) alone, for patients who have achieved a complete pathological response (pCR) following neoadjuvant chemotherapy (NACT). The study design involves the histological confirmation of pCR using vacuum-assisted biopsy (VABB) or vacuum-assisted excision (VAE) guided by ultrasound. The primary objective is to demonstrate that the non-surgical, RT-only treatment and follow-up approach is not inferior to the traditional surgical approach in patients with pCR after NACT.
This description comes directly from the study's public registry record.
Elisabetta Rossi, MD · +39-0294372191 · ElisabettaMariaCristina.Rossi@ieo.it
Always discuss trial participation with your own doctor first.
| Istituto di Candiolo IRCCS | Candiolo, Turin, Italy | Not Yet Recruiting |
| European Institute of Oncology | Milan, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06281210